1
|
Wang Q, Tiffen J, Bailey CG, et al:
Targeting amino acid transport in metastatic castration-resistant
prostate cancer: effects on cell cycle, cell growth and tumor
development. J Natl Cancer Inst. 105:1463–1473. 2013. View Article : Google Scholar : PubMed/NCBI
|
2
|
Chen C, Chen SM, Xu B, et al: In vivo and
in vitro study on the role of 3,3′-diindolylmethane in treatment
and prevention of nasopharyngeal carcinoma. Carcinogenesis.
34:1815–1821. 2013. View Article : Google Scholar : PubMed/NCBI
|
3
|
Xu Y, Zhang J and Dong WG:
Indole-3-carbinol (I3C)-induced apoptosis in nasopharyngeal cancer
cells through Fas/FasL and MAPK pathway. Med Oncol. 28:1343–1348.
2011. View Article : Google Scholar
|
4
|
Banerjee S, Kong D, Wang Z, Bao B, Hillman
GG and Sarkar FH: Attenuation of multi-targeted
proliferation-linked signaling by 3,3′-diindolylmethane (DIM): from
bench to clinic. Mutat Res. 728:47–66. 2011. View Article : Google Scholar : PubMed/NCBI
|
5
|
Chen Z, Tao ZZ, Chen SM, Chen C, Li F and
Xiao BK: Indole-3-carbinol inhibits nasopharyngeal carcinoma growth
through cell cycle arrest in vivo and in vitro. PloS one.
8:e822882013. View Article : Google Scholar : PubMed/NCBI
|
6
|
Kim SJ, Lee JS and Kim SM:
3,3′-Diindolylmethane suppresses growth of human esophageal
squamous cancer cells by G1 cell cycle arrest. Oncol Rep.
27:1669–1673. 2012.PubMed/NCBI
|
7
|
Blackburn EH: Switching and signaling at
the telomere. Cell. 106:661–673. 2001. View Article : Google Scholar : PubMed/NCBI
|
8
|
Shay JW and Wright WE: Senescence and
immortalization: role of telomeres and telomerase. Carcinogenesis.
26:867–874. 2005. View Article : Google Scholar
|
9
|
Tadi K, Chang Y, Ashok BT, et al:
3,3′-Diindolylmethane, a cruciferous vegetable derived synthetic
anti-proliferative compound in thyroid disease. Biochem Biophys Res
Commun. 337:1019–1025. 2005. View Article : Google Scholar : PubMed/NCBI
|
10
|
Nicastro HL, Firestone GL and Bjeldanes
LF: 3,3′-Diindolylmethane rapidly and selectively inhibits
hepatocyte growth factor/c-Met signaling in breast cancer cells. J
Nutr Biochem. 24:1882–1888. 2013. View Article : Google Scholar : PubMed/NCBI
|
11
|
Zhu J, Li Y, Guan C and Chen Z:
Anti-proliferative and pro-apoptotic effects of
3,3′-diindolylmethane in human cervical cancer cells. Oncol Rep.
28:1063–1068. 2012.PubMed/NCBI
|
12
|
Li Y, Wang Z, Kong D, et al: Regulation of
FOXO3a/beta-catenin/GSK-3beta signaling by 3,3′-diindolyl-methane
contributes to inhibition of cell proliferation and induction of
apoptosis in prostate cancer cells. J Biol Chem. 282:21542–21550.
2007. View Article : Google Scholar : PubMed/NCBI
|
13
|
Bhuiyan MM, Li Y, Banerjee S, et al:
Down-regulation of androgen receptor by 3,3′-diindolylmethane
contributes to inhibition of cell proliferation and induction of
apoptosis in both hormone-sensitive LNCaP and insensitive C4-2B
prostate cancer cells. Cancer Res. 66:10064–10072. 2006. View Article : Google Scholar : PubMed/NCBI
|
14
|
Lagah S, Tan IL, Radhakrishnan P, et al:
RHPS4 G-quadruplex ligand induces anti-proliferative effects in
brain tumor cells. PloS one. 9:e861872014. View Article : Google Scholar : PubMed/NCBI
|
15
|
Guo WQ, Li LZ, He ZY, et al:
Anti-proliferative effects of Atractylis lancea (Thunb) DC via
down-regulation of the c-myc/hTERT/telomerase pathway in Hep-G2
cells. Asian Pac J Cancer Prev. 14:6363–6367. 2013. View Article : Google Scholar
|
16
|
Meng Q, Qi M, Chen DZ, et al: Suppression
of breast cancer invasion and migration by indole-3-carbinol:
associated with up-regulation of BRCA1 and E-cadherin/catenin
complexes. J Mol Med (Berl). 78:155–165. 2000. View Article : Google Scholar
|
17
|
Kong D, Li Y, Wang Z, Banerjee S and
Sarkar FH: Inhibition of angiogenesis and invasion by
3,3′-diindolylmethane is mediated by the nuclear factor-kappaB
downstream target genes MMP-9 and uPA that regulated
bioavailability of vascular endothelial growth factor in prostate
cancer. Cancer Res. 67:3310–3319. 2007. View Article : Google Scholar : PubMed/NCBI
|
18
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: the next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
19
|
Mukherjee S, Firpo EJ, Wang Y and Roberts
JM: Separation of telomerase functions by reverse genetics. Proc
Natl Acad Sci USA. 108:E1363–E1371. 2011. View Article : Google Scholar : PubMed/NCBI
|
20
|
Martinez P and Blasco MA: Telomeric and
extratelomeric roles for telomerase and the telomere-binding
proteins. Nat Rev Cancer. 11:161–176. 2011. View Article : Google Scholar
|
21
|
Park JI, Venteicher AS, Hong JY, et al:
Telomerase modulates Wnt signalling by association with target gene
chromatin. Nature. 460:66–72. 2009. View Article : Google Scholar : PubMed/NCBI
|
22
|
Cong Y and Shay JW: Actions of human
telomerase beyond telomeres. Cell Res. 18:725–732. 2008. View Article : Google Scholar : PubMed/NCBI
|
23
|
Fujiwara T, Kagawa S and Tazawa H:
Synergistic interaction of telomerase-specific oncolytic
virotherapy and chemotherapeutic agents for human cancer. Curr
Pharm Biotechnol. 13:1809–1816. 2012. View Article : Google Scholar
|
24
|
Zhao L and Wink M: The beta-carboline
alkaloid harmine inhibits telomerase activity of MCF-7 cells by
down-regulating hTERT mRNA expression accompanied by an accelerated
senescent phenotype. Peer J. 1:e1742013. View Article : Google Scholar
|
25
|
Qian X, Cheng J, Chen A, et al: Long-term
effects of short hairpin RNA-targeted human telomerase reverse
transcriptase on suppression of SGC-7901 cell proliferation by
inhibition of telomerase activity. Oncol Rep. 19:575–581.
2008.PubMed/NCBI
|
26
|
Zou L, Zhang P, Luo C and Tu Z:
shRNA-targeted hTERT suppress cell proliferation of bladder cancer
by inhibiting telomerase activity. Cancer Chemother Pharmacol.
57:328–334. 2006. View Article : Google Scholar
|
27
|
Pang LY and Argyle D: Cancer stem cells
and telomerase as potential biomarkers in veterinary oncology. Vet
J. 185:15–22. 2010. View Article : Google Scholar : PubMed/NCBI
|
28
|
McCaul JA, Gordon KE, Minty F, Fleming J
and Parkinson EK: Telomere dysfunction is related to the intrinsic
radio-resistance of human oral cancer cells. Oral Oncol.
44:261–269. 2008. View Article : Google Scholar
|
29
|
Ahmad A, Sakr WA and Rahman KW: Mechanisms
and therapeutic implications of cell death induction by indole
compounds. Cancers. 3:2955–2974. 2011. View Article : Google Scholar : PubMed/NCBI
|
30
|
Fan S, Meng Q, Xu J, et al: DIM
(3,3′-diindolylmethane) confers protection against ionizing
radiation by a unique mechanism. Proc Natl Acad Sci USA.
110:18650–18655. 2013. View Article : Google Scholar
|
31
|
Wiatrak BJ: Overview of recurrent
respiratory papillomatosis. Curr Opin Otolaryngol Head Neck Surg.
11:433–441. 2003. View Article : Google Scholar : PubMed/NCBI
|